Publication list


Breast Surgery Division
1 Imoto S, Wada N, Hasebe T, Ochiai A, Ebihara S, Moriyama N. Sentinel node biopsy for breast cancer patients in Japan. Biomed Pharmacother 2002;56 Suppl 1:192s-95s.
2 Matsuoka Y, Nakano T, Inagaki M, Sugawara Y, Akechi T, Imoto S, Murakami K, Yamawaki S, Uchitomi Y. Cancer-related intrusive thoughts as an indicator of poor psychological adjustment at 3 or more years after breast surgery: a preliminary study. Breast Cancer Res Treat 2002;76:117-24.
3 Nakano T, Wenner M, Inagaki M, Kugaya A, Akechi T, Matsuoka Y, Sugahara Y, Imoto S, Murakami K, Uchitomi Y. Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. Am J Psychiatry 2002;159:2087-93.
4 Hasebe T, Sasaki S, Imoto S, Ochiai A. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study. Mod Pathol 2002;15:904-13.
5 Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 2002;15:502-16.
6 Imoto S, Ebihara S, Moriyama N. Is sentinel node biopsy practical? JMAJ 2002;45:444-48.
 
Colorectal (pelvic) Surgery Division
1 Ishikawa F, Saito N, Koda K, Takiguchi N, Oda K, Suzuki M, Nunomura M, Sarashina H, Miyazaki M. Nuclear morphometric analysis of T2 lesions of the rectum-a simple, reporoducible method for predicting malignancy potential. The American Journal of Surgery. 2002;183(16):686-91.
2 Tsuda N, Nonaka Y, Shichijo S, Yamada A, Ito M, Maeda Y, Harada M, Kamura T, Itoh K. UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumor antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumor. Br J Cancer. 2002;87(9):1006-12.
3 Maeda Y., Ito M., Harashima N., Nakatsura T., Hida N., Imai N., Sato Y., Shichijo S., Todo S., Tyoh K. Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients. Int J Cancer.2002;99(3):409-17.
4 Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur J Immunol 2002;32(3):826-36.
5 Gotohda N, Nakagohri N, Saito N, Ono M, Sugito M, Ito M, Inoue K, Oda T, Takahashi S, Kinoshita K. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepato-Gastroenterol 2002, (in press).
6 Kosugi C, Saito N, Murakami K, Ono M, Sugito M, Ito M, Morihiro M, Tonooka T, Sato K, Koda K, Miyazaki M. Positron emission tomography for preoperative staging of colorectal carcinoma: correlation with histopathologic examination and computed tomography in lymph node metastasis. Dis Colon Rectum 2002. (in press)
7 Koda K, Glassy MC, McKnight ME, Yasutomi J, Saito N, Dan M, Nakajima N.FImmunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.FAnticancer Res. 2001;21(1B):621-7
 
Diagnostic Radiology Division
1 Nasu K., Kuroki Y., Nawano S., Murakami K., Kuroki S., Sekiguchi R., Hayashi T., Umeda T. Thoracic cage extent of melorheostosis depicted by multislice CT. Skeletal Radiol,2002;31:464-66
2 Kuroki Y., Nawano S., Hasebe T., Imoto S., Nasu K., Murakami K., Satake M., Sekiguchi R., Hayashi T. Efficacy of MR Mammography(MRM) in providing preoperative locoregional information on breast cancer: correlation between MRM and histological findings. Magnetic Resonance in Medical Sciences 2002;1:73-80
 
Digestive Endoscopy and Gastrointestinal Oncology Division
1 Morihiro M, Boku N, Ohtsu A, Miyamoto S, Ishikura S. Advanced Esophageal Cancer with Esophago-bronchial Fistula Successfully Treated by Chemoradiation Therapy with Additional Endoscopic Resection: a case report. Jpn J Clin Oncol 2002;32(2):59-63
2 Ikeda N, Shimada Y, Ohtsu A, Boku N, Tsuji Y, Saito H, Koizumi W, Iwase H, Yoshida S, Fukuda H. A phase II Study of doxifluridine in elderly patients with advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9410).Jpn J Clin Oncol 2002;32(3):90-4.
3 Miyamoto S, Muto M, Hamamoto Y, Boku N, Ohstu A, Baba S, Yoshida M, Ohkuwa M, Hosokawa K, Tajiri H, Yoshida S. A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms.Gastrointestinal Endoscopy 2002;55(4):576-81.
4 Mitachi Y, Sakata Y, Ohtsu A, Hyodo I, Katsu K, Sairenji M, Saitoh S, Suwa T, Sato T, Miyata Y. Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study. Gastric cancer 2002;5:160-7.
5 Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H, Ochiai A, Biopsy specimen microvessel densitiy is a useful prognostic marker in patients with T2-4M0 esophageal cancer treated with chemoradiotherapy. Clinical Cancer Research 2002;8: 124-30.
6 Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-volding Lesions with synchronous and metachronous esophageal squamous cell carcinima in patients with head and neak cancer. Gastrointestinal Endoscopy 2002;56(4):517-22.
7 Muto M, Nakane M, Hitomi Y, Yoshida S, Sasaki S, Ohtsu A, Yoshida S, Ebihara S, Esumi H. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancarization in patients with head and neck cancer. Carcinogenesis 2002;23(10): 1759-65.
8 Fu K-I, Muto M, Mera K, Sano Y, Nagashima F, Tahara M, Boku N, Ohtsu A, Kanomata N, Ochiai A, Yoshida S. Carcinoma coexisting with esophageal leiomyoma. Gastrointest Endosc 2002;56:272-3.
9 Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, Watanabe H, Fukuda H, Yoshimizu H. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 2002;23:1851-9.
10 Katada C, Muto M, Manabe T, Boku N, Ohtsu A, Yoshida S. Esophageal stenosis after endoscopic mucosal resection for superficial esophageal lesions. Gastrointest Endosc (in press)
11 Tonooka T, Sano Y, Fujii T, Kato S, Yoshino T, Fu KI, Hironaka S, OchiaiA, Yoshida S. Adenocarcinoma in solitary large hyperplastic polyp diagnosed by magnifying colonoscope: report of a case. Dis Colon Rectum. 2002;45(10):1407-11.
12 Fujimori T, Fujii S, Kitajima K, Nishi M, Sano Y. Initial transformed cells of colorectal adenoma: do they occur at the top of the crypt? J Gastroenterol 2002;37(11):982-4.
13 Sanbongi M, Igarashi M, Sano Y, Yoshida S, Gono K, Yamaguchi M, Oyama N.Analysis of spectal reflectance using normalization method from endoscopic spectroscopy system. Optical Review 2002;9(6):238-43.
14 Sano Y, Kuga R, KI Fu, Yoshino T, Ochiai A, Yoshida S, Fujii T. Superficially elevated colonic adenoma changed to undetectable configulation on ordinary Endoscopy during treatment with preferential cyclooxygenase-2 inhibitor. J Gastroenterol (in press)
15 Sano Y, Maeda N. Early colon cancer in serrated adenoma. Jpn J Clin Oncol 2002;32 (2):pp1-2.
16 Manabe T, Sano Y. Early colon cancer changed in shape in ashort period. Jpn J Clin Oncol 2002;32(12):pp1-2.
17 Saito Y, Fujii T, Akasu T, Gotoda T, Kozu T, Saito D, Sano Y. Development of an aggressive depressed cancer in a case of familial adenomatous polyposis. Endoscopy 2002;34(5):421-3.
18 Fu KI, Sano Y, Kato Y, Fujii T, Arao J, Yoshino T, Sugito M, Ono M, Saito N, Yoshida S. Colonic perforation after endoscopic biopsy of a submucosal tumor: successful conservative treatment. Dig Endoscopy 2002;14(4):181-3.
19 Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S. Randomized phase III trial of 5-fluorouracil alone versus 5-Fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin C in patients with unresectable advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol 2003;21:54-59
20

Ohtsu A, Boku N, Yoshioka T, Hyodo I, Shirao K, Shimada Y, Saito H, Nakamura A, Yamamoto S, Yoshida S. A Phase II study of irinotecan in combination with 120-hour infusion of 5-Fluorouracil in patients with metastatic colorectal carcinoma: the Japan Clinical Oncology Group Study (JCOG9703). Jpn J Clin Oncol 33:28-32,2003.

21 Okuno T, Fu KI, Sano Y, Yoshino T, Murakami K, Ochiai A, Yoshida S. Early colon cancers detected by 18FDG-PET: a report of two cases with immunohistochemical investigation. Hepato-gastroenterolgy (in press)
22 Hosokawa A, Yamada Y, Shimada Y, Muro K, Matsumura Y, Shirao K, Fujita S, Akasu T, Moriya Y. Weekly Hepatic Arterial Infusion of 5-Fluorouracil and Subsequent Systemic Chemotherapy for Liver Metastases from Colorectal Cancer. Jpn J Clin Oncol (in press)
23 Hosokawa A, Shimada Y, Shirao K, Matsumura Y, Yamada Y, Muro K, Hamaguchi T, Gotoh M, Shimoda T. Long-term Survivor of Gastric Small Cell Carcinoma. Hepato-Gastroentererology (in press)
 
Head & Neck Surgery Division
1 Kimata Y, Uchiyama K, Sakuraba M, Ebihara S, Hayashi R, Haneda T, Onitsuka T, Asakage T, Nakatsuka T, Harii K. Velopharyngeal function after microsurgical reconstruction of lateral and superior oropharyngeal defects. Laryngoscope 2002;112:1037-42.
2 Uchiyama K, Kimata Y, Sakuraba M, Ebihara S. Evaluating the donor site after harvesting of free jejunum. Head Neck 2002;24:451-455.
3 Sakuraba M, Kimata Y, Ota Y, Uchiyama K, Kishimoto S, Harii K, Ebihara S. Simple maxillary reconstruction using free tissue transfer and prostheses. Plast Reconstr Surg (in press)
4 Kimata Y, Sakuraba M, Hishinuma S, Ebihara S, Hayashi R, Asakage T, Nakatsuka T, Harii K. Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy. Laryngoscope (in press)
5 Kimata Y, Sakuraba M, Hishinuma S, Ebihara S, Hayashi R, Asakage T. Free vascularized nerve grafting for immediate facial nerve reconstruction. Brit J Plast Surg (in press)
6 Kimata Y. The deep circumflex iliac perforator flap with iliac crest for mandibular reconstruction. Clin Plast Surg (in press)
 
Hepatobiliary & Pancreatic Oncology and Surgery Division
1 Ishikura S, Ogino T, Furuse J, Satake M, Baba S, Kawashima M, Nihei K, Ito Y, Maru Y, Ikeda H. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 2002 ;25:189-93.
2 Abe T, Furuse J, Yoshino M, Kinoshita T, Konishi M, Inoue K, Hasebe T. Clinical characteristics of hepatocellular carcinoma with a high degree of lymph nodes metastases at the onset. Am J Clin Oncol, 25:318-23, 2002.
3 Tamai F, Furuse J, Maru Y, Yoshino M, Kinoshita T. Intrahepatic arterial pseudoaneurysm: a complication after radio-frequency ablation therapy for hepatocellular carcinoma. Eur J Radiol, 2002;44:40.
4 Furuse J, Ishii H, Onaya H, Satake M, Nose H, Mikami S, Sakai H, Kiyomi M, Maru Y, Yoshino M. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol (in press).
5 Ishii H, Furuse J, Nagase M, Yoshino M, Kawashima M, Satake M, Ogino T, Ikeda H. Hepatic arterial infusion of 5-fluorouracil and extra-beam radiotherapy for liver metastases from pancreatic carcinoma. Hepato-Gastroenterology (in press).
6 Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M. Intraoperative and conformal external beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer (in press).
7 Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and SH U 508A to differentiate hepatocellular carcinoma. Br J Radiol (in press).
8 Ishii H, Furuse J, Nagase M, Kawashima M, Ikeda H, Yoshino M. Relief of jaundice in patients with extrahepatic cholangiocarcinoma by external and internal radiotherapy: results without indwelling stents. Hepato-Gastroenterology (in press).
 
Oncology/Hematology Division
1 Itoh K, Ohtsu T, Fukuda H, Sasaki Y, Ogura M, Morishima Y, Chou T, Aikawa K, Uike N, Mizorogi F, Ohno T, Ikeda S, Sai T, Taniwaki M, Kawano F, Niimi M, Hotta T, Shimoyama M, Tobinai K:Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol 2002;13:1347-55.
2 Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y, Morishima Y, Murate T, Kasai M, Uike N, Taniwaki M, Kano Y, Ohnishi K, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K. Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol 2002;13:928-43.
3 Saeki M, Ozawa S, Saito Y, Jinno H, Hamaguchi T, Nokihira H, Shimada Y, Kunitoh H, Yamamoto N, Ohe Y, Yamada Y, Shirao K, Muto M, Mera K, Goto K, Ohmatsu H, Kubota K, Niho S, Kakinuma R, Minami, H, Ohtsu A, Yoshida T, Saijo N, Sawada J. Three novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokin 2002;17: SNP24 (488)-26 (490).
 
Palliative Care and Psychiatric Service
1 Akechi T, Nakano T, Akizuki N, Nakanishi T, Yoshikawa E, Okamura H, Uchitomi Y. Clinical factors associated with suicidality in cancer patients. Jpn J Clin Oncol 2002;32:506-11.
2 Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Predictive factors for suicidal ideation in patients with unresectable lung carcinoma; a 6 month follow-up study. Cancer 2002;95:1085-93.
3 Akizuki N, Okamura H, Akechi T, Nakano T, Yoshikawa E, Nakanishi T, Uchitomi Y. Clinical experience of the pharmacological treatment algorithm for major depression in advanced cancer patients; a preliminary study. Int J Psychiatry Clin Pract 2002;6:83-9.
4 Inagaki M, Akizuki N, Kugaya A, Fujii H, Akechi T, Uchitomi Y. Metyrapone for Cushing's syndrome. Am J Psychiatry 2002;159:1246.
5 Matsuoka Y, Nakano T, Inagaki M, Sugawara Y, Akechi T, Imoto S, Murakami K, Yamawaki S, Uchitomi Y. Cancer-related intrusive thoughts as an indicator of poor psychological adjustment at 3 or more years after breast surgery; a preliminary study. Breast Cancer Res Treat 2002;76:117-24.
6 Morita T, Akechi T, Sugawara Y, Chihara S, Uchitomi Y. Practices and attitudes of Japanese oncologists an palliative care physicians concerning terminal sedation; a nationwide survey. J Clin Oncol 2002;20:758-64.
7 Nakanishi T, Nukariya K, Kasahara H, Ushijima S, Hirai K, Akechi T, Okamura H, Uchitomi Y. Psychological distress of family members with cancer patients in Japan. Int J Psychiatry Clin Pract 2002;6:205-10.
8 Nakano T, Wenner M, Inagaki M, Kugaya A, Akechi T, Matsuoka Y, Sugahara Y, Imoto S, Murakami K, Uchitomi Y. Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. Am J Psychiatry 2002;159:2087-93.
9 Sugawara Y, Akechi T, Shima Y, Okuyama T, Akizuki N, Nakano T, Uchitomi Y. Efficacy of methylphenidate for fatigue in advanced cancer patients; a preliminary study. Palliat Med 2002;16:261-63.
10 Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Factors correlated with dyspnea in advanced lung cancer patients; organic causes and what else? J Pain Symptom Manage 2002;23:490-500.
11 Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002;23:484-9.
12 Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002;23:417-23.
13 Uchitomi Y, Kugaya A, Akechi T, Nakano T, Inagaki M, Matsuoka Y, Kagaya A, Yamawaki S. Lack of association between suicidal ideation and enhanced platelet 5-HT2A receptor-mediated calcium mobilization in cancer patients with depression. Biol Psychiatry 2002;52:1159-65.
14 Uchitomi Y, Mikami I, Nagai K, Nishiwaki Y, Akechi T, Okamura H. Depression and psychological distress in patients during the year after curative resection of non-small cell lung cancer. J Clin Oncol 2003;21:69-77.
15 Morita T. Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Sympom Manage 2002;24:447-53.
16 Morita T, Shima Y, Adachi I, for Japan Palliative Oncology Group. Attitudes of Japanese physicians toward terminal dehydration: A national survey. J Clin Oncol 2002; 24:4699-704.
17 Akechi T, Nakano T, Akizuki N, Nakanishi T, Yoshikawa E, Okamura H, Uchitomi Y. Psychiatric evaluation of competency in cancer patients. Int J Psychiatry Clin Pract (in press)
18 Akechi T, Nakano T, Akizuki N, Okamura M, Sakuma K, Nakanishi T, Yoshikawa E, Uchitomi Y. Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics (in press)
19 Fukui S, Koike M, Ooba A, Uchitomi Y. The effect of a psychosocial group intervention on loneliness and social support for Japanese women with primary breast cancer. Oncol Nurs Forum (in press)
20 Matsuoka Y, Yamawaki S, Inagaki M, Akechi T, Uchitomi Y. A volumetric study of amygdala in cancer survivors with intrusive recollections. Biol Psychiatry (in press)
21 Morita T, Hirai K, Akechi T, Uchitomi Y. Similarity and difference among standard medical care, palliative sedation therapy, and euthanasia; a multidimensional scaling analysis on physicians' and general population's opinion. J Pain Symptom Manage (in press)
22 Okuyama T, Wang X S, Akechi T, Mendoza T R, Hosaka T, Cleeland C S, Uchitomi Y. Validation study of the Japanese Version of the Brief Fatigue Inventory. J Pain Symptom Manage (in press)
 
Plastic & Reconstructive Surgery Division
1 Kimata, Y, Uchiyama, K, Sakuraba, M, Ebihara, S, Hayashi, R, Haneda, T, Onitsuka, T, Asakage, T, Nakatsuka, T and Harii, K. Velopharyngeal Function after Microsurgical Reconstruction of Lateral and Superior Oropharyngeal Defects. Laryngoscope 2002;112:1037-42.
2 Uchiyama, K, Kimata Y, Sakuraba, M, and Ebihara, S. Evaluating the Donor Site After Harvesting of Free Jejunum. Head and Neck 2002;24:451-5.
3 Sakuraba, M, Kimata Y, Ota, Y, Uchiyama, K, Kishimoto, S, Harii, K and Ebihara, S. Simple maxillary reconstruction using free tissue transfer and prostheses. Plastic and Reconstructive Surgery. (in press).
4 Kimata Y, Sakuraba M, Hishinuma S, Ebihara S, Hayashi R, Asakage T, Nakatsuka T, Harii K. Analysis of the Relations Between the Shape of the Reconstructed Tongue and Postoperative Functions After Subtotal or Total Glossectomy. Laryngoscope (in press).
5 Kimata Y, Sakuraba M, Hishinuma S, Ebihara S, Hayashi R, Asakage T. Free Vascularized Nerve Grafting for Immediate Facial Nerve Reconstruction. Brit J Plast Surg (in press).
6 Kimata Y. The deep circumflex iliac perforator flap with iliac crest for mandibular reconstruction. Clinics in Plastic Surgery (in press).
 
Radiation Oncology Division
1 Ikeda, H: Editorial: Quality assurance activities in radiotherapy. Jpn J Clin Oncol 2002;32: 493 -6.
2 Tanisada, K, Teshima, T, Ohno, Y, Inoue, T, Abe, M, Ikeda, H, Owen, JB, Hanks, GE, Masuda, K, Honke, Y, Japanese PCS Working Group: Patterns of Care Study quantitative evaluation of the quality of radiotherapy in Japan. Cancer 2002;95:164-71.
3 Nihei, K, Ishikura, S, Kawashima, M, Ogino, T, Ikeda, H: Short-course palliative radiotherapy for airway stenosis in non-small cell lung cancer. Int J Clin Oncol 2002;7:284-88.
4 Uno, T, Sumi, M, Ikeda, H, Teshima, T, Yamashita, M, Inoue, T, Japanese PCS Working Subgroup of Lung Cancer: Radiation therapy for small-cell lung cancer: results of the 1995-1997 patterns of care process survey in Japan. Lung Cancer 2002;35:279-85.
5 Ishikura, S, Ogino, T, Furuse, J, Satake, M, Baba, S, Kawashima, M, Nihei, K, Ito, Y, Maru, Y, Ikeda, H: Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombosis. Am J Clin Oncol 2002;25:189-93.
6 Ito, Y, Kamijo, T, Yokose, T, Kawashima, M, Ogino, T, Ikeda, H, Hayashi, R, Sasaki, S, Ochiai, A: Microvessel density predicts the radiosensitivity of metastatic head and neck squamous cell carcinoma in cervical lymph nodes. Int J Oncol 2001;19:1127-32.
7 Sekine I. Nishiwaki Y., Ogino T., Yokoyama A., Saito M., Tsukiyama I., Tsuchiya S., Hayakawa K., Yoshimura K., Ishizuka N., Saijo N. Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindecine for unresectable stage III non-small cell lung cancer: Japan Clinical Oncology Group Study 9306. J Clin Oncol 2002;20:797-803
 
Thoracic Oncology and Surgery Division
1 Ohe Y, Yamamoto S, Suzuki K, Hojo F, Kakinuma R, Matsumoto T, Ohmatsu H, Nishiwaki Y:Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 2001;37:54-63.
2 Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N:Irinotecan Plus Cisplatin Compared with Etoposide Plus Cisplatin for Extensive Small-Cell Lung Cancer. N Engl J Med 2002,346:85-91.
3 Sekine I, Nishiwaki Y, Ogino T, Yokoyama A, Saito M, Mori K, Tsukiyama I, Tsuchiya S, Hayakawa K, Yoshimura K, Ishizuka N, Watanabe K, and Saijo N. Phase II Study of Twice-Daily High-Dose Thoracic Radiotherapy Alternating With Cisplatin and Vindesine for Unresectable Stage III Non-Small-Cell Lung Cancer: Japan Clinical Oncology Group Study 9306. J Clin Oncol 2002;20:797-803. 
4 Niho S, Ohe Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Nishiwaki Y. Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer. Lung cancer 2002;35:209-14.
5 Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. Screening for Lung Cancer With Low-Dose Helical Computed Tomography: Anti-Lung Cancer Association Project. J Clin Oncol 2002;20:911-20.
6 Matsumoto T, Ohashi Y, Morita S, Kobayashi K, Shibuya M, Yamaji, Eguchi K, Fukuoka M, Nagao K, Nishiwaki Y, Niitani H. Thequality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer. Qual Life Res 2002;11:483-93.
7 Ohde Y, Yokose T, Yoshida J, Matsumoto T, Nagai K. Encapsulated thymoma metastasizing to a pectoralis major muscle. Jpn J Thorac Cardiovasc Surg 2002;50:260-2.
8 Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A. Localized pure ground-glass opacity on high-resolution CT:histologic characteristics. J Comput Assist Tomogr 2002;26:323-29.
9 Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002;23:484-9.
10 Takada M, Fukuoka M, Kawahara M, SugiuraT, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, FukudaH, and Saijo N. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3054-60.
11 Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Predictive factors for suicidal ideation in patients with unresectable lung carcinoma; A 6-month follow-up study. Cancer 2002;95:1085-93.
12 Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002;81:33-7.
13 Harada M, Yokose T, Yoshida J, Nishiwaki Y, Nagai K. Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung. Lung Cancer 2002; 38:177-84.
14 Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R and Nishiwaki Y. Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study. Brit J Cancer 2002, 87: 1360-4.
15 Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection Lung Cancer. 2002;124: 499-502.
16 Shimizu K, Nagai K, Yoshida J, Nishimura M, Hayashi R, Yokose T. Successful management of solitary malar metastasis from lung cancer. Lung Cancer. 2002; 36; 337-9.
17 Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T. A Randomized Trial Comparing Induction Chemotherapy Followd by Surgery with Surgery Alone in Stage VA N2 Non-Small Cell Lung Cancer Patients(JCOG9209). J Thorac Cardiovasc Surg.


Table of Contents